STOCK TITAN
  1. Home
  2. Sec-filings
  3. NEUP
  4. [8-K] Neuphoria Therapeutics Inc. Reports Material Event

[8-K] Neuphoria Therapeutics Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock NEUP logo
Neuphoria Therapeutics Inc

NASDAQ:NEUP

NEUP Rankings

#5700 Ranked by Market Cap
N/A Ranked by Dividends

NEUP Latest News

Sep 4, 2025
Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)
Aug 28, 2025
Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
May 27, 2025
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
May 20, 2025
Neuphoria Provides First Quarter 2025 Business Updates
Apr 15, 2025
Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

NEUP Latest SEC Filings

Sep 2, 2025
[Form 4] Neuphoria Therapeutics Inc. Insider Trading Activity
Jul 29, 2025
[424B5] Neuphoria Therapeutics Inc. Prospectus Supplement (Debt Securities)

NEUP Stock Data

22.41M
2.25M
0.53%
67.79%
0.64%
Biotechnology
Pharmaceutical Preparations
Link
United States
BURLINGTON